IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter and IN.PACT 018 Paclitax
Medtronic, Inc. · Decision date Dec 30, 2014
What did the FDA approve?
FDA approved PMA P140010 on December 30, 2014, for the IN.PACT Admiral Paclitaxel-Coated PTA Balloon Catheter. The approval statement covers percutaneous transluminal angioplasty after predilatation of de novo or restenotic lesions up to 180 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4–7 mm.
The applicant was Medtronic, Inc., and the device is classified as a drug-eluting peripheral transluminal angioplasty catheter under product code ONU. The record does not state whether this was an original approval or a supplement, and no supplement type or reason is provided. The statement describes the reported intended use; it does not independently establish safety or clinical effectiveness.
FDA approval order statement
FOR THE IN.PACT ADMIRAL PACLITAXEL-COATED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER. THIS DEVICE IS INDICATED FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, AFTER PREDILATATION, OF DE NOVO OR RESTENOTIC LESIONS UP TO 180 MM IN LENGTH IN NATIVE SUPERFICIAL FEMORAL OR POPLITEAL ARTERIES WITH REFERENCE VESSEL DIAMETERS OF 4-7 MM.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 30, 2014
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P140010
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic, Inc.
- Product code
- ONU
- Decision code
- APPR
- Decision date
- Dec 30, 2014
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug-Eluting Peripheral Transluminal Angioplasty Catheter.
- Applicant
- Medtronic, Inc.
- Product code
- ONU
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P140010 received
Application receipt date recorded by FDA.
P140010 · FDA decision
APPR
P140010/S106 · Related supplement
IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter
Timeline entries are records held by MedtechLedger for P140010. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140010
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3576 Unocal Pl., Santa Rosa, CA, 95403
Sources and methodology
- Original FDA record: P140010
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records